Tresiba (insulin degludec) is a prescription drug that’s used to manage high blood sugar in people with diabetes. Tresiba’s cost may depend on your dosage, your health insurance, and the pharmacy you ...
SAN FRANCISCO—Sanofi’s Toujeo has been battling it out against Novo Nordisk’s Tresiba in the next-generation basal insulin market, but new data could give it an edge in one key pool of diabetes ...
* Says Tresiba demonstrated lower day-to-day and within-day variability in glucose-lowering effect compared with insulin glargine u300 Sign up here. * Says phase 1 study showed that the day-to-day ...
Novo Nordisk (NVO) said new data from a phase 3a trial showed that more people with type 2 diabetes achieved blood sugar target with once-weekly insulin icodec compared with its own once-daily therapy ...
Novo Nordisk added the final piece to the puzzle the Danish drugmaker wanted to complete before submitting its once-weekly insulin icodec to regulators next year. Icodec already notched notable wins ...
(RTTNews) - Danish pharmaceutical company Novo Nordisk A/S is recalling 1,468 product samples of Levemir, Tresiba, Fiasp, Novolog and Xultophy to the consumer level, due to improper storage ...
COPENHAGEN, Sept 28 (Reuters) - Denmark's Novo Nordisk A/S, the world's biggest insulin producer, said on Friday its diabetes treatment Tresiba had been approved in Japan. Novo Nordisk said in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback